Price
No data yet.
Social Signal Score
Revenue
$0.00Company Profile
- CEO
- Joel Mark Shulman CISM, CISSP,
- Sector
- Financial Services
- Industry
- Shell Companies
- Beta
- 0.00
- Country
- US
Financials
APN has only 8 quarterly periods on file — the charts below show the full history available.
Net Income
$962.5KEBITDA
$-838.0KFree Cash Flow
$-298.1KEPS (diluted)
$0.06Shares Outstanding (diluted)
16.73M-22.4%Operating Expenses
$0.00Cash & Debt
$16.41MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2022 | $0.00 | $5.23M | $0.31 |
| 2021 | $0.00 | $1.21M | $0.06 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from APN's reported EPS growth of 453.6% a year over 1 year. Historical EPS growth of 454% reflects a recovery from a low base and won't persist. Capped at 30% as a starting point.
- EPS in 5 years
- $1.16
- Implied price
- $38.33
- Return from $10.37
- 29.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $19.06 — today's price is already 45.6% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 23 | 28 | 33 | 38 | 43 |
|---|---|---|---|---|---|
| 20.0% | 11.5% | 16.0% | 19.9% | 23.3% | 26.4% |
| 25.0% | 16.2% | 20.9% | 24.9% | 28.5% | 31.7% |
| 30.0% | 20.8% | 25.7% | 29.9% | 33.6% | 36.9% |
| 35.0% | 25.5% | 30.5% | 34.9% | 38.7% | 42.2% |
| 40.0% | 30.1% | 35.4% | 39.9% | 43.9% | 47.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsproactiveinvestors.co.uk·6h ago·Positive
Deutsche Bank raises Applied Nutrition target on £160m revenue forecast Applied Nutrition PLC (LSE:APN) drew an increased target price from Deutsche Bank on Thursday, as the broker lifted its valuation following a strong pre-close trading update from the supplement maker. The shares traded around 316.5p as Deutsche Bank maintained its 'buy' rating and raised its target from 335p to 350p on sustained operational momentum.
View source ↗
Insider trading
Open-market buys and sells by APN officers and directors.
- Bought
- $148.0m
- Sold
- —
40 trades
0 trades
- Harbinger Capital Partners Master Fund I, Ltd.bought
- Harbinger Capital Partners Master Fund I, Ltd.bought
- Harbinger Capital Partners Master Fund I, Ltd.bought
- Harbert Management Corpbought
- Harbert Management Corpbought
- Harbert Management Corpbought
- Harbert Management Corpbought
- Harbert Management Corpbought
20 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.